Skip to main content
Clinical Trials/NCT04784377
NCT04784377
Completed
Not Applicable

High Intensity Versus Low Level Laser Therapy in Treatment of Patients With Subacromial Impingement Syndrome: A Randomized, Double-blind, Controlled Trial.

Cairo University1 site in 1 country42 target enrollmentMarch 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Subacromial Impingement Syndrome
Sponsor
Cairo University
Enrollment
42
Locations
1
Primary Endpoint
pain intensity
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Shoulder pain is the third most common musculoskeletal problem after lumbar and neck diseases in clinical practice, and the most common cause of shoulder pain is subacromial impingement syndrome. The main goal of treatment is to reduce pain and to solve the mechanical problem that causes functional impairment. Low-level laser treatment is an increasingly used treatment modality in the treatment of subacromial impingement syndrome as in many musculoskeletal diseases, as it promotes cell proliferation and tissue regeneration by its anti-inflammatory and photobiostimulation properties. Also, High-intensity laser therapy is a treatment method that is gaining popularity in the recent years. These ultra-short impulses effect a deep action in the biological tissue (3-4 cm), with a homogeneous distribution of the light source in the irradiated soft tissue, but without excessive thermal enhancements. It reduces pain and edema with photomechanic effects in deep tissues. As far as the investigators know, there are no studies comparing these two treatment modalities in subacromial impingement syndrome yet. This study was planned to compare the efficacy of High-intensity laser therapy and low-intensity laser therapy in treatment of patients with subacromial impingement syndrome.

Registry
clinicaltrials.gov
Start Date
March 15, 2021
End Date
September 15, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marwa Shafiek Mustafa Saleh

assistance professor doctor

Cairo University

Eligibility Criteria

Inclusion Criteria

  • shoulder pain for at least one month
  • male and female patients with age range from 25-45 years old
  • positive impingement test results
  • stage I or II disease according to the Neer classification, confirmed by MRI
  • visual analog scale score greater than 40 mm.

Exclusion Criteria

  • patients will be excluded if they have:
  • major trauma to the shoulder
  • stage III subacromial impingement syndrome
  • diabetes mellitus
  • hypothyroidism
  • calcific tendinitis
  • adhesive capsulitis (forward flexion less than 160, horizontal abduction less than 160
  • installation of cardiac pacemaker
  • history of a physical therapy program for the same shoulder in the last 6 months.

Outcomes

Primary Outcomes

pain intensity

Time Frame: change from base line at three weeks

Pain will be evaluated by a visual analogue scale (VAS). The patient will be asked to mark the severity of pain on a 100-mm line with "no pain" on one end and "most unbearable pain" on the other end

Secondary Outcomes

  • Pittsburgh Sleep Quality Index (PSQI)(change from baseline at three weeks)
  • pain pressure threshold(change from baseline at three weeks)
  • shoulder range of motion(change from baseline at three weeks)
  • Shoulder Pain and Disability Index(change from baseline at three weeks)

Study Sites (1)

Loading locations...

Similar Trials